1. Home
  2. CBRS vs IQV Comparison

CBRS vs IQV Comparison

Compare CBRS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cerebras Systems Inc. Class A Common Stock

CBRS

Cerebras Systems Inc. Class A Common Stock

HOLD

Current Price

$115.45

Market Cap

39.0B

Sector

Technology

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$274.39

Market Cap

43.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBRS
IQV
Founded
2016
1982
Country
United States
United States
Employees
N/A
93000
Industry
Semiconductors
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.0B
43.1B
IPO Year
2024
2013

Fundamental Metrics

Financial Performance
Metric
CBRS
IQV
Price
$115.45
$274.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
20
Target Price
$282.55
★ $309.76
AVG Volume (30 Days)
★ 8.8M
1.1M
Earning Date
11-12-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 4.67
EPS
N/A
★ 5.24
Revenue
N/A
★ $9,739,000,000.00
Revenue This Year
$73.94
$7.10
Revenue Next Year
$232.73
$6.36
P/E Ratio
★ N/A
$53.27
Revenue Growth
N/A
★ 41.60
52 Week Low
$105.36
$154.50
52 Week High
$265.63
$284.50

Technical Indicators

Market Signals
Indicator
CBRS
IQV
Relative Strength Index (RSI) 33.24 56.23
Support Level N/A $252.55
Resistance Level $221.60 $274.49
Average True Range (ATR) 9.64 9.16
MACD -0.87 0.63
Stochastic Oscillator 18.07 62.82

Price Performance

Historical Comparison
CBRS
IQV

About CBRS Cerebras Systems Inc. Class A Common Stock

Cerebras Systems Inc is an AI company. It designs the world's fastest AI infrastructure for training and inference. The company builds the world's largest semiconductor as well as the AI systems to power, cool, and feed the processors data. It develops software to link these systems together into industry-leading supercomputers that are simple to use even for the most complicated AI work, using familiar ML frameworks like PyTorch. Customers use its supercomputers to train industry-leading models. The company uses these supercomputers to run inference at speeds unobtainable from alternative commercial technologies. It delivers these AI capabilities to its customers on-premise and via the cloud. The company generates the majority of its revenue from the USA.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: